Skip to content

Long-term prognosis in a phase II study of limited resection for the patient having pulmonary adenocarcinoma with ground glass opacity selected by High-Resolution CT and PET findings

Long-term prognosis in a phase II study of limited resection for the patient having pulmonary adenocarcinoma with ground glass opacity selected by High-Resolution CT and PET findings - Long-term prognosis in a phase II study of limited resection for the patient having pulmonary adenocarcinoma with ground glass opacity selected by High-Resolution CT and PET findings

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046487
Enrollment
73
Registered
2021-12-27
Start date
2021-11-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary adenocarcinoma with ground glass opacity

Interventions

Limited resection is performed for the patient having pulmonary adenocarcinoma with ground glass opacity, lower FDG uptake than mediastinum, and suspicion of the non-invasive carcinoma by intraoperati

Sponsors

Japan Northeast Thoracic Surgical Study Group (JNETS)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: pulmonary adenocarcinoma 20mm or smaller in HR-CT findings ground glass opacity is dominant in HR-CT findings maximum diameter of the consolidation is shorter than 20% of the maximum diameter of the tumor in HR-CT findings FDG uptake of the tumor is lower than that of mediastinum cT1N0M0 possible for lobectomy written informed consent non-invasive carcinoma is suspected by intraoperative pathological examination

Exclusion criteria

Exclusion criteria: multiple cancer within 10 years preoperative treatment

Design outcomes

Primary

MeasureTime frame
10-year survival rate

Secondary

MeasureTime frame
proportion of local recurrence, relapse-free survival,

Countries

Japan

Contacts

Public ContactHirohisa Kato

Yamagata University, Faculty of Medicine Department of Surgery 2

h-kato@med.id.yamagaya-u.ac.jp023-628-5342

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026